Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1992 1
1996 2
1997 2
1998 1
2000 1
2002 1
2003 1
2004 1
2005 1
2006 2
2007 3
2008 3
2010 3
2011 10
2012 7
2013 13
2014 6
2015 10
2016 10
2017 10
2018 13
2019 12
2020 7
2021 13
2022 25
2023 25
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perera V, Ward JW, Hiebert L, Degenhardt L, Hajarizadeh B, Colledge S, Hickman M, Jawad D, Lazarus JV, Matthews GV, Scheibe A, Vickerman P, Dore GJ, Grebely J; Global HCV and HIV Treatment Restrictions Group. Marshall AD, et al. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):366-382. doi: 10.1016/S2468-1253(23)00335-7. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367631 Review.
CTCF and BORIS in genome regulation and cancer.
Marshall AD, Bailey CG, Rasko JE. Marshall AD, et al. Curr Opin Genet Dev. 2014 Feb;24:8-15. doi: 10.1016/j.gde.2013.10.011. Epub 2013 Dec 14. Curr Opin Genet Dev. 2014. PMID: 24657531 Review.
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs.
Grebely J, Collins AB, Artenie AA, Sutherland R, Meyer JP, Barocas JA, Falade-Nwulia O, Cepeda JA, Cunningham EB, Hajarizadeh B, Lafferty L, Lazarus JV, Bonn M, Marshall AD, Treloar C. Grebely J, et al. Among authors: marshall ad. Int J Drug Policy. 2021 Oct;96:103469. doi: 10.1016/j.drugpo.2021.103469. Epub 2021 Oct 2. Int J Drug Policy. 2021. PMID: 34610884 No abstract available.
Relational impacts of capitalization in early parenthood.
Le Y, Fredman SJ, Marshall AD, Chow SM, McDaniel BT, Laurenceau JP, Feinberg ME. Le Y, et al. Among authors: marshall ad. J Fam Psychol. 2022 Feb;36(1):69-79. doi: 10.1037/fam0000847. Epub 2021 Mar 25. J Fam Psychol. 2022. PMID: 33764085 Free PMC article. Clinical Trial.
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update.
Cooke GS, Flower B, Cunningham E, Marshall AD, Lazarus JV, Palayew A, Jia J, Aggarwal R, Al-Mahtab M, Tanaka Y, Jeong SH, Poovorawan K, Waked I, Hiebert L, Khue PM, Grebely J, Alcantara-Payawal D, Sanchez-Avila JF, Mbendi C, Muljono DH, Lesi O, Desalegn H, Hamid S, de Araujo A, Cheinquer H, Onyekwere CA, Malyuta R, Ivanchuk I, Thomas DL, Pimenov N, Chulanov V, Dirac MA, Han H, Ward JW. Cooke GS, et al. Among authors: marshall ad. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):346-365. doi: 10.1016/S2468-1253(23)00321-7. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367629 Review.
The miracle man.
Marshall AD. Marshall AD. Rehabil Nurs. 1997 Jan-Feb;22(1):40-1. doi: 10.1002/j.2048-7940.1997.tb02071.x. Rehabil Nurs. 1997. PMID: 9110843 No abstract available.
A gender lens is needed in hepatitis C elimination research.
Larney S, Madden A, Marshall AD, Martin NK, Treloar C. Larney S, et al. Among authors: marshall ad. Int J Drug Policy. 2022 May;103:103654. doi: 10.1016/j.drugpo.2022.103654. Epub 2022 Mar 17. Int J Drug Policy. 2022. PMID: 35306279
163 results